Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
POTTER v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al
Case Number:
3:15-cv-07658
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Bandas Law Firm
- Bressler Amery
- Brodsky Smith
- Calcagni & Kanefsky
- Carella Byrne
- Chiesa Shahinian
- Cleary Gottlieb
- Cohen Milstein
- Cohn Lifland
- Critchley Kinum
- Debevoise & Plimpton
- Entwistle & Cappucci
- Fisher & Phillips
- Fleischman Bonner
- Frier Levitt
- Gibbons PC
- Hach Rose Schirripa
- Hartmann Doherty
- Kasowitz Benson
- Kessler Topaz
- Kirby McInerney
- Kranjac Tripodi
- Kroll Heineman
- Lite DePalma
- Lowenstein Sandler
- McCarter & English
- McElroy Deutsch
- McKenney & Froelich
- Midlige Richter
- Mintz Levin
- O'Melveny & Myers
- Patunas Law
- Robinson Miller
- Rolnick Kramer
- Safirstein Law
- Schulte Roth
- Seeger Weiss
- Skoloff & Wolfe
- Trief & Olk
- Whipple Azzarello
- Winston & Strawn
Companies
- AIG Retirement Services Co.
- Alleghany Corp.
- Bank of America Corp.
- Barclays PLC
- Bausch Health Cos. Inc.
- BMO Capital Markets Corp.
- CapSpecialty Inc.
- Citigroup Inc.
- Conagra Brands Inc.
- Deutsche Bank AG
- DNB ASA
- GIC Private Ltd.
- HSBC Holdings PLC
- Janus Henderson Group PLC
- JPMorgan Chase & Co.
- Lord Abbett & Co. LLC
- Massachusetts Mutual Life Insurance Co.
- Minnesota Life Insurance Co.
- Morgan Stanley
- Multi-Color Corp.
- Pacific Compensation Insurance Co.
- PricewaterhouseCoopers LLP
- RBC Capital Markets
- Securian Financial Group Inc.
- SIFMA
- TD Securities Inc.
- Teacher Retirement System of Texas
- Teachers Insurance & Annuity Association of America
- The Boeing Co.
- The Goldman Sachs Group Inc.
- The Northwestern Mutual Life Insurance Co.
- Transatlantic Holdings Inc.
- T. Rowe Price Group Inc.
- Two Sigma Investments LP
- United Services Automobile Association
- ValueAct Capital Management LP
Government Agencies
Sectors & Industries:
-
November 09, 2018
Options Broker Must Stay In TIAA-Led Class In Valeant Suit
An options brokerage can't break away from a consolidated securities class action against Valeant Pharmaceuticals, a New Jersey federal judge ruled after finding that it was too early to tell whether the firm's interests would diverge from the larger pool of equity investors led by TIAA.
-
August 08, 2018
TIAA Says It Should Be Only Lead Plaintiff In Valeant Suit
Lead plaintiff TIAA urged a New Jersey federal judge on Tuesday to strike a brokerage firm's bid to lead a subclass of Valeant options investors in a multibillion-dollar consolidated securities class action against the pharma giant, warning that the firm's request risks splintering the suit and driving up costs for all involved.
-
May 01, 2017
Valeant Securities Fraud Case Lives, Could Lose Debt Claims
A New Jersey federal judge allowed a multibillion-dollar securities class action against Valeant Pharmaceuticals International Inc. and its top officials to move forward on Friday, although claims related to $15 billion in corporate debt that was issued under allegedly fraudulent pretenses may be cut.
-
December 15, 2016
Valeant Offering Needn't Meet Public Standards, SIFMA Says
The Securities Industry and Financial Markets Association urged a New Jersey federal court Wednesday to reject an attempt to hold Valeant Pharmaceuticals International Inc.'s private securities sale up to public sale standards.
-
September 14, 2016
Valeant Says Investors' Suit Is Based On Hindsight
A proposed class of investors claiming Valeant Pharmaceuticals International Inc. fraudulently hid questionable relationships with specialty pharmacies and is liable for a massive stock drop relied on hindsight following a "perfect storm" of negative publicity and hasn't actually shown proof of any fraud, the company said Tuesday in New Jersey federal court.
-
May 31, 2016
Robbins Geller Will Lead Valeant Securities Fraud Suit
A New Jersey federal judge on Tuesday appointed a teacher's retirement fund as lead plaintiff and Robbins Geller Rudman & Dowd LLP as lead counsel in consolidated related class actions alleging that Valeant Pharmaceuticals International Inc. fraudulently inflated its stock price, causing the fund to suffer more than $90 million in losses.
-
December 22, 2015
Robbins Geller Looks To Lead Valeant Securities Fraud Suit
A teacher's retirement fund that alleges Valeant Pharmaceuticals fraudulently inflated its stock price, causing the fund to lose more than $90 million, asked a New Jersey federal court Monday to consolidate four related putative class actions and name it lead plaintiff with Robbins Geller Rudman & Dowd LLP as lead counsel.
-
October 23, 2015
Valeant Hit With Investor Suit Over Pharmacy Ties
Valeant Pharmaceuticals International Inc. fraudulently concealed questionable relationships with specialty pharmacies and is liable for steep losses that shareholders suffered after the relationships came to light, according to a proposed securities class action filed Thursday in New Jersey federal court.
- ← Previous
- 1
- 2
- Next →